Drawing for [SCRIPT-BIT]

USPTO serial 85862838

[SCRIPT-BIT]

Reviewed by CopyMark Law Group

Reg. 4431649Status 710
Filing date
Status date
Registration date
Nov 12, 2013
Examiner
SPARER, ZACHARY R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with [SCRIPT-BIT]?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori T. Milvain

LORI T. MILVAIN LATHAM, SHUKER, EDEN & BEAUDINE, LLP111 N MAGNOLIA AVE STE 1400ORLANDO, FL 32801-2367UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Health care services, namely, providing a database in the field of pharmaceuticals information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment informationSECTION 8 - CANCELLEDApr 16, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2020C8..CANCELLED SEC. 8 (6-YR)
Nov 12, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 22, 2013ALIEASSIGNED TO LIE
Jul 1, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2013XAECEXAMINER'S AMENDMENT ENTERED
Jun 17, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 17, 2013GNEAEXAMINERS AMENDMENT E-MAILED
Jun 17, 2013CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 12, 2013DOCKASSIGNED TO EXAMINER
Mar 6, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance